The FDA Just Rejected a Bid for MDMA’s Approval to Treat PTSD

1 year ago 54
ARTICLE AD BOX
The regulatory agency has asked drugmaker Lykos Therapeutics to run an additional study on the use of the psychedelic drug in patients with post-traumatic stress disorder.
Read Entire Article